News summary

CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies

Source: PR Newswire • Published: 01 Oct 2026, 21:08

Summarized by Masters of Longevity from PR Newswire.

A biotech press release about a collaborative research program pursuing new methods for preserving and transporting therapeutic cells at room temperature, inviting readers curious about innovations in cell-therapy logistics and biopreservation.

CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies
Key Takeaways
  • ARPA-H awarded up to $7.3 million to a BoSS program team led by Likarda to advance ambient cell preservation.
  • CaseBioscience will contribute clinical media formulation, biopreservation, and cellular metabolism expertise to develop long-term ambient stabilization methods.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.MoL PickSeed Oils and Health: Inflammation, Processing and EvidenceHuman trials, processing risks and long-term health ask different questions. What can seed-oil research tell us—and what remains unresolved?